Selected research
Market Analysis & Forecast
Global Medical Examination Market Analysis and Forecast 2026-2032
Market perspective
The global Medical Examination market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Medical Examination is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Medical Examination is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Medical Examination is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Medical Examination is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Medical Examination include AcuMed Medical., Bupa, Cleveland Clinic, Cooper Aerobics, Health 100, IKang Group, Japanese Red Cross, Kaiser Permanente and Lifescan Medical Centre, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Medical Examination, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Medical Examination, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Examination, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Examination revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Examination market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Examination revenue, projected growth trends, production technology, application and end-user industry.
Medical Examination Segment by Company
AcuMed Medical.
Bupa
Cleveland Clinic
Cooper Aerobics
Health 100
IKang Group
Japanese Red Cross
Kaiser Permanente
Lifescan Medical Centre
Mayo Clinic
Mediway Medical
Milord Health Group
Nuffield Health
PL Tokyo Health Care Center
Raffles Medical Group
Rich Healthcare
Samsung Total Healthcare Center
Seoul Medicare
Seoul National University Hospital
St. Luke’s International Hospital
Sun Medical Center
Tokyo Midtown Clinic
Medical Examination Segment by Type
Routine Physical Examination
Comprehensive Physical Examination
Others
Medical Examination Segment by Application
Enterprise
Individuals
Medical Examination Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Examination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Examination and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Examination.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Medical Examination in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Medical Examination company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Examination revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Routine Physical Examination
- Comprehensive Physical Examination
- Others
Applications
- Enterprise
- Individuals
Companies covered
- AcuMed Medical.
- Bupa
- Cleveland Clinic
- Cooper Aerobics
- Health 100
- IKang Group
- Japanese Red Cross
- Kaiser Permanente
- Lifescan Medical Centre
- Mayo Clinic
- Mediway Medical
- Milord Health Group
- Nuffield Health
- PL Tokyo Health Care Center
- Raffles Medical Group
- Rich Healthcare
- Samsung Total Healthcare Center
- Seoul Medicare
- Seoul National University Hospital
- St. Luke’s International Hospital
- Sun Medical Center
- Tokyo Midtown Clinic
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Medical Examination Market by Type
- 1.2.1 Global Medical Examination Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Routine Physical Examination
- 1.2.3 Comprehensive Physical Examination
- 1.2.4 Others
- 1.3 Medical Examination Market by Application
- 1.3.1 Global Medical Examination Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Enterprise
- 1.3.3 Individuals
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical Examination Market Dynamics
- 2.1 Medical Examination Industry Trends
- 2.2 Medical Examination Industry Drivers
- 2.3 Medical Examination Industry Opportunities and Challenges
- 2.4 Medical Examination Industry Restraints
3 Global Growth Perspective
- 3.1 Global Medical Examination Market Perspective (2021-2032)
- 3.2 Global Medical Examination Growth Trends by Region
- 3.2.1 Global Medical Examination Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Medical Examination Market Size by Region (2021-2026)
- 3.2.3 Global Medical Examination Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Medical Examination Revenue by Players
- 4.1.1 Global Medical Examination Revenue by Players (2021-2026)
- 4.1.2 Global Medical Examination Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Medical Examination Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Medical Examination Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Medical Examination Key Players Headquarters & Area Served
- 4.4 Global Medical Examination Players, Product Type & Application
- 4.5 Global Medical Examination Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Medical Examination Market CR5 and HHI
- 4.6.3 2025 Medical Examination Tier 1, Tier 2, and Tier 3
5 Medical Examination Market Size by Type
- 5.1 Global Medical Examination Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Medical Examination Revenue by Type (2021-2032)
- 5.3 Global Medical Examination Revenue Market Share by Type (2021-2032)
6 Medical Examination Market Size by Application
- 6.1 Global Medical Examination Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Medical Examination Revenue by Application (2021-2032)
- 6.3 Global Medical Examination Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 AcuMed Medical.
- 7.1.1 AcuMed Medical. Company Information
- 7.1.2 AcuMed Medical. Business Overview
- 7.1.3 AcuMed Medical. Medical Examination Revenue and Gross Margin (2021-2026)
- 7.1.4 AcuMed Medical. Medical Examination Product Portfolio
- 7.1.5 AcuMed Medical. Recent Developments
- 7.2 Bupa
- 7.2.1 Bupa Company Information
- 7.2.2 Bupa Business Overview
- 7.2.3 Bupa Medical Examination Revenue and Gross Margin (2021-2026)
- 7.2.4 Bupa Medical Examination Product Portfolio
- 7.2.5 Bupa Recent Developments
- 7.3 Cleveland Clinic
- 7.3.1 Cleveland Clinic Company Information
- 7.3.2 Cleveland Clinic Business Overview
- 7.3.3 Cleveland Clinic Medical Examination Revenue and Gross Margin (2021-2026)
- 7.3.4 Cleveland Clinic Medical Examination Product Portfolio
- 7.3.5 Cleveland Clinic Recent Developments
- 7.4 Cooper Aerobics
- 7.4.1 Cooper Aerobics Company Information
- 7.4.2 Cooper Aerobics Business Overview
- 7.4.3 Cooper Aerobics Medical Examination Revenue and Gross Margin (2021-2026)
- 7.4.4 Cooper Aerobics Medical Examination Product Portfolio
- 7.4.5 Cooper Aerobics Recent Developments
- 7.5 Health 100
- 7.5.1 Health 100 Company Information
- 7.5.2 Health 100 Business Overview
- 7.5.3 Health 100 Medical Examination Revenue and Gross Margin (2021-2026)
- 7.5.4 Health 100 Medical Examination Product Portfolio
- 7.5.5 Health 100 Recent Developments
- 7.6 IKang Group
- 7.6.1 IKang Group Company Information
- 7.6.2 IKang Group Business Overview
- 7.6.3 IKang Group Medical Examination Revenue and Gross Margin (2021-2026)
- 7.6.4 IKang Group Medical Examination Product Portfolio
- 7.6.5 IKang Group Recent Developments
- 7.7 Japanese Red Cross
- 7.7.1 Japanese Red Cross Company Information
- 7.7.2 Japanese Red Cross Business Overview
- 7.7.3 Japanese Red Cross Medical Examination Revenue and Gross Margin (2021-2026)
- 7.7.4 Japanese Red Cross Medical Examination Product Portfolio
- 7.7.5 Japanese Red Cross Recent Developments
- 7.8 Kaiser Permanente
- 7.8.1 Kaiser Permanente Company Information
- 7.8.2 Kaiser Permanente Business Overview
- 7.8.3 Kaiser Permanente Medical Examination Revenue and Gross Margin (2021-2026)
- 7.8.4 Kaiser Permanente Medical Examination Product Portfolio
- 7.8.5 Kaiser Permanente Recent Developments
- 7.9 Lifescan Medical Centre
- 7.9.1 Lifescan Medical Centre Company Information
- 7.9.2 Lifescan Medical Centre Business Overview
- 7.9.3 Lifescan Medical Centre Medical Examination Revenue and Gross Margin (2021-2026)
- 7.9.4 Lifescan Medical Centre Medical Examination Product Portfolio
- 7.9.5 Lifescan Medical Centre Recent Developments
- 7.10 Mayo Clinic
- 7.10.1 Mayo Clinic Company Information
- 7.10.2 Mayo Clinic Business Overview
- 7.10.3 Mayo Clinic Medical Examination Revenue and Gross Margin (2021-2026)
- 7.10.4 Mayo Clinic Medical Examination Product Portfolio
- 7.10.5 Mayo Clinic Recent Developments
- 7.11 Mediway Medical
- 7.11.1 Mediway Medical Company Information
- 7.11.2 Mediway Medical Business Overview
- 7.11.3 Mediway Medical Medical Examination Revenue and Gross Margin (2021-2026)
- 7.11.4 Mediway Medical Medical Examination Product Portfolio
- 7.11.5 Mediway Medical Recent Developments
- 7.12 Milord Health Group
- 7.12.1 Milord Health Group Company Information
- 7.12.2 Milord Health Group Business Overview
- 7.12.3 Milord Health Group Medical Examination Revenue and Gross Margin (2021-2026)
- 7.12.4 Milord Health Group Medical Examination Product Portfolio
- 7.12.5 Milord Health Group Recent Developments
- 7.13 Nuffield Health
- 7.13.1 Nuffield Health Company Information
- 7.13.2 Nuffield Health Business Overview
- 7.13.3 Nuffield Health Medical Examination Revenue and Gross Margin (2021-2026)
- 7.13.4 Nuffield Health Medical Examination Product Portfolio
- 7.13.5 Nuffield Health Recent Developments
- 7.14 PL Tokyo Health Care Center
- 7.14.1 PL Tokyo Health Care Center Company Information
- 7.14.2 PL Tokyo Health Care Center Business Overview
- 7.14.3 PL Tokyo Health Care Center Medical Examination Revenue and Gross Margin (2021-2026)
- 7.14.4 PL Tokyo Health Care Center Medical Examination Product Portfolio
- 7.14.5 PL Tokyo Health Care Center Recent Developments
- 7.15 Raffles Medical Group
- 7.15.1 Raffles Medical Group Company Information
- 7.15.2 Raffles Medical Group Business Overview
- 7.15.3 Raffles Medical Group Medical Examination Revenue and Gross Margin (2021-2026)
- 7.15.4 Raffles Medical Group Medical Examination Product Portfolio
- 7.15.5 Raffles Medical Group Recent Developments
- 7.16 Rich Healthcare
- 7.16.1 Rich Healthcare Company Information
- 7.16.2 Rich Healthcare Business Overview
- 7.16.3 Rich Healthcare Medical Examination Revenue and Gross Margin (2021-2026)
- 7.16.4 Rich Healthcare Medical Examination Product Portfolio
- 7.16.5 Rich Healthcare Recent Developments
- 7.17 Samsung Total Healthcare Center
- 7.17.1 Samsung Total Healthcare Center Company Information
- 7.17.2 Samsung Total Healthcare Center Business Overview
- 7.17.3 Samsung Total Healthcare Center Medical Examination Revenue and Gross Margin (2021-2026)
- 7.17.4 Samsung Total Healthcare Center Medical Examination Product Portfolio
- 7.17.5 Samsung Total Healthcare Center Recent Developments
- 7.18 Seoul Medicare
- 7.18.1 Seoul Medicare Company Information
- 7.18.2 Seoul Medicare Business Overview
- 7.18.3 Seoul Medicare Medical Examination Revenue and Gross Margin (2021-2026)
- 7.18.4 Seoul Medicare Medical Examination Product Portfolio
- 7.18.5 Seoul Medicare Recent Developments
- 7.19 Seoul National University Hospital
- 7.19.1 Seoul National University Hospital Company Information
- 7.19.2 Seoul National University Hospital Business Overview
- 7.19.3 Seoul National University Hospital Medical Examination Revenue and Gross Margin (2021-2026)
- 7.19.4 Seoul National University Hospital Medical Examination Product Portfolio
- 7.19.5 Seoul National University Hospital Recent Developments
- 7.20 St. Luke’s International Hospital
- 7.20.1 St. Luke’s International Hospital Company Information
- 7.20.2 St. Luke’s International Hospital Business Overview
- 7.20.3 St. Luke’s International Hospital Medical Examination Revenue and Gross Margin (2021-2026)
- 7.20.4 St. Luke’s International Hospital Medical Examination Product Portfolio
- 7.20.5 St. Luke’s International Hospital Recent Developments
- 7.21 Sun Medical Center
- 7.21.1 Sun Medical Center Company Information
- 7.21.2 Sun Medical Center Business Overview
- 7.21.3 Sun Medical Center Medical Examination Revenue and Gross Margin (2021-2026)
- 7.21.4 Sun Medical Center Medical Examination Product Portfolio
- 7.21.5 Sun Medical Center Recent Developments
- 7.22 Tokyo Midtown Clinic
- 7.22.1 Tokyo Midtown Clinic Company Information
- 7.22.2 Tokyo Midtown Clinic Business Overview
- 7.22.3 Tokyo Midtown Clinic Medical Examination Revenue and Gross Margin (2021-2026)
- 7.22.4 Tokyo Midtown Clinic Medical Examination Product Portfolio
- 7.22.5 Tokyo Midtown Clinic Recent Developments
8 North America
- 8.1 North America Medical Examination Revenue (2021-2032)
- 8.2 North America Medical Examination Revenue by Type (2021-2032)
- 8.2.1 North America Medical Examination Revenue by Type (2021-2026)
- 8.2.2 North America Medical Examination Revenue by Type (2027-2032)
- 8.3 North America Medical Examination Revenue Share by Type (2021-2032)
- 8.4 North America Medical Examination Revenue by Application (2021-2032)
- 8.4.1 North America Medical Examination Revenue by Application (2021-2026)
- 8.4.2 North America Medical Examination Revenue by Application (2027-2032)
- 8.5 North America Medical Examination Revenue Share by Application (2021-2032)
- 8.6 North America Medical Examination Revenue by Country
- 8.6.1 North America Medical Examination Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Medical Examination Revenue by Country (2021-2026)
- 8.6.3 North America Medical Examination Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
9 Europe
- 9.1 Europe Medical Examination Revenue (2021-2032)
- 9.2 Europe Medical Examination Revenue by Type (2021-2032)
- 9.2.1 Europe Medical Examination Revenue by Type (2021-2026)
- 9.2.2 Europe Medical Examination Revenue by Type (2027-2032)
- 9.3 Europe Medical Examination Revenue Share by Type (2021-2032)
- 9.4 Europe Medical Examination Revenue by Application (2021-2032)
- 9.4.1 Europe Medical Examination Revenue by Application (2021-2026)
- 9.4.2 Europe Medical Examination Revenue by Application (2027-2032)
- 9.5 Europe Medical Examination Revenue Share by Application (2021-2032)
- 9.6 Europe Medical Examination Revenue by Country
- 9.6.1 Europe Medical Examination Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Medical Examination Revenue by Country (2021-2026)
- 9.6.3 Europe Medical Examination Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
10 China
- 10.1 China Medical Examination Revenue (2021-2032)
- 10.2 China Medical Examination Revenue by Type (2021-2032)
- 10.2.1 China Medical Examination Revenue by Type (2021-2026)
- 10.2.2 China Medical Examination Revenue by Type (2027-2032)
- 10.3 China Medical Examination Revenue Share by Type (2021-2032)
- 10.4 China Medical Examination Revenue by Application (2021-2032)
- 10.4.1 China Medical Examination Revenue by Application (2021-2026)
- 10.4.2 China Medical Examination Revenue by Application (2027-2032)
- 10.5 China Medical Examination Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Medical Examination Revenue (2021-2032)
- 11.2 Asia Medical Examination Revenue by Type (2021-2032)
- 11.2.1 Asia Medical Examination Revenue by Type (2021-2026)
- 11.2.2 Asia Medical Examination Revenue by Type (2027-2032)
- 11.3 Asia Medical Examination Revenue Share by Type (2021-2032)
- 11.4 Asia Medical Examination Revenue by Application (2021-2032)
- 11.4.1 Asia Medical Examination Revenue by Application (2021-2026)
- 11.4.2 Asia Medical Examination Revenue by Application (2027-2032)
- 11.5 Asia Medical Examination Revenue Share by Application (2021-2032)
- 11.6 Asia Medical Examination Revenue by Country
- 11.6.1 Asia Medical Examination Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Medical Examination Revenue by Country (2021-2026)
- 11.6.3 Asia Medical Examination Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Medical Examination Revenue (2021-2032)
- 12.2 SAMEA Medical Examination Revenue by Type (2021-2032)
- 12.2.1 SAMEA Medical Examination Revenue by Type (2021-2026)
- 12.2.2 SAMEA Medical Examination Revenue by Type (2027-2032)
- 12.3 SAMEA Medical Examination Revenue Share by Type (2021-2032)
- 12.4 SAMEA Medical Examination Revenue by Application (2021-2032)
- 12.4.1 SAMEA Medical Examination Revenue by Application (2021-2026)
- 12.4.2 SAMEA Medical Examination Revenue by Application (2027-2032)
- 12.5 SAMEA Medical Examination Revenue Share by Application (2021-2032)
- 12.6 SAMEA Medical Examination Revenue by Country
- 12.6.1 SAMEA Medical Examination Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Medical Examination Revenue by Country (2021-2026)
- 12.6.3 SAMEA Medical Examination Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst